Invesco’s AbbVie ABBV Stock Holding History

Invesco’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-24,800	Closed	-$1.88M	–	3646
2019 Q3	$1.88M	Hold	24,800	–	–	﹤0.01%	2674
2019 Q2	$1.8M	Hold	24,800	–	–	﹤0.01%	2758
2019 Q1	$2M	Buy	24,800 +8,300	+50%	+$679K	﹤0.01%	2610
2018 Q4	$1.52M	Hold	16,500	–	–	﹤0.01%	2726
2018 Q3	$1.56M	Buy	+16,500	New	+$1.56M	﹤0.01%	2924
2017 Q1	–	Sell	-600	Closed	-$38K	–	3692
2016 Q4	$38K	Hold	600	–	–	﹤0.01%	3670
2016 Q3	$38K	Hold	600	–	–	﹤0.01%	3646
2016 Q2	$37K	Hold	600	–	–	﹤0.01%	3671
2016 Q1	$34K	Hold	600	–	–	﹤0.01%	3684
2015 Q4	$36K	Hold	600	–	–	﹤0.01%	3719
2015 Q3	$33K	Buy	+600	New	+$39.1K	﹤0.01%	3763

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco's ABBV Position: Q1 2026 in Review

Invesco reduced its AbbVie (ABBV) stake by 3.8% in Q1 2026, selling an estimated $68.6M and leaving 7,798,048 shares worth $1.7B. The position accounts for 0.17% of the portfolio, ranked #106.

Invesco first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.85B in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Invesco held 7,798,048 shares of AbbVie worth $1.7B as of Q1 2026.
Invesco sold 309,432 AbbVie shares in Q1 2026, an estimated $68.6M.
AbbVie made up 0.17% of Invesco's portfolio in Q1 2026, its #106 holding.
Invesco first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Invesco's AbbVie position peaked at $1.85B in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.